BRAF and neoplasm: We recently reported CRC expressing a BRAF-mutated signature 6, which strongly overlaps with the methylation-based group of Hinoue 11, and a MSI-like gene expression group that captures the hypermutant tumours of TCGA 13, indicating the potential for identification of robust biological subgroups.